CYCLACEL PHARMACEUTICALS - CYCC 6 PERP (CYCCP) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:CYCCP • US23254L2079

5.05 USD
-0.23 (-4.36%)
Last: Sep 11, 2025, 08:00 PM
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to CYCCP. The Buy consensus is the weighted average rating of the current analysts ratings.

  • CYCCP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about CYCCP.
  • In the previous month the buy percentage consensus was at a similar level.
  • CYCCP was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
CYCCP Historical Analyst RatingsCYCCP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -127 -115 -103 -91 -79 -67 -55 -43 -31 -19 -7 2 4 6 8
CYCCP Current Analyst RatingCYCCP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades

CYCLACEL PHARMACEUTICALS - CYCC 6 PERP / CYCCP FAQ

What is the consensus rating for CYCLACEL PHARMACEUTICALS - CYCC 6 PERP (CYCCP) stock?

The consensus rating for CYCLACEL PHARMACEUTICALS - CYCC 6 PERP (CYCCP) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


How many analysts cover CYCLACEL PHARMACEUTICALS - CYCC 6 PERP (CYCCP) stock?

The number of analysts covering CYCLACEL PHARMACEUTICALS - CYCC 6 PERP (CYCCP) is 6.